Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Erratum for Bernier et al., J Am Soc Nephrol 17 (1) 232-243.
J Am Soc Nephrol 17: 591-, 2006
© 2006 American Society of Nephrology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Errata


   Correction
Top
 Correction
 
Bernier et al.: Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus. J Am Soc Nephrol 17: 232–243, 2006.

In this article, the authors regretfully report an error in a plasma concentration datum. The second sentence of the first full paragraph in the right-hand column on page 239 should read as follows (bold text indicates corrected information):

A 300-mg dose of the F1 formulation was reported in the Clinical Investigator Brochure to increase plasma concentration to 18.5 ng/ml (30 nanomolar, MW of SR49059 is 620.5) 3 h after the administration of SR49059 to normal volunteers.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP